8-K Announcements
6Apr 28, 2026·SEC
Apr 24, 2026·SEC
Mar 30, 2026·SEC
Universal Health Services, Inc. (UHS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Universal Health Services, Inc. (UHS) stock price & volume — 10-year historical chart
Universal Health Services, Inc. (UHS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Universal Health Services, Inc. (UHS) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 27, 2026 | $5.62vs $5.41+3.9% | $4.5Bvs $4.4B+2.5% |
| Q1 2026 | Feb 25, 2026 | $5.88vs $5.92-0.7% | $4.5Bvs $4.5B-0.4% |
| Q4 2025 | Oct 27, 2025 | $5.69vs $4.66+22.1% | $4.5Bvs $4.5B-0.2% |
| Q3 2025 | Jul 28, 2025 | $5.35vs $4.92+8.7% | $4.3Bvs $4.2B+1.1% |
Universal Health Services, Inc. (UHS) competitors in Hospitals and inpatient facilities — business model, growth, and fundamentals comparison
Universal Health Services, Inc. (UHS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Universal Health Services, Inc. (UHS) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 10.41B | 10.77B | 11.38B | 11.56B | 12.64B | 13.4B | 14.28B | 15.83B | 17.36B | 17.76B |
| Revenue Growth % | 6.59% | 3.48% | 5.63% | 1.59% | 9.37% | 5.99% | 6.59% | 10.82% | 9.71% | 10.42% |
| Cost of Goods Sold | 1.11B | 1.17B | 1.25B | 1.29B | 1.43B | 1.47B | 1.53B | 1.59B | 1.66B | 1.26B |
| COGS % of Revenue | 10.62% | 10.85% | 11% | 11.14% | 11.29% | 11% | 10.73% | 10.03% | 9.55% | - |
| Gross Profit | 9.3B▲ 0% | 9.6B▲ 3.2% | 10.13B▲ 5.4% | 10.27B▲ 1.4% | 11.21B▲ 9.2% | 11.93B▲ 6.3% | 12.75B▲ 6.9% | 14.24B▲ 11.7% | 15.71B▲ 10.3% | 12.01B▲ 0% |
| Gross Margin % | 89.38% | 89.15% | 89% | 88.86% | 88.71% | 89% | 89.27% | 89.97% | 90.45% | 67.62% |
| Gross Profit Growth % | 6.52% | 3.21% | 5.45% | 1.42% | 9.19% | 6.33% | 6.91% | 11.69% | 10.29% | - |
| Operating Expenses | 8.02B | 8.43B | 8.91B | 8.91B | 9.85B | 10.92B | 11.57B | 12.56B | 13.71B | 10.47B |
| OpEx % of Revenue | 77.09% | 78.24% | 78.32% | 77.1% | 77.93% | 81.51% | 81.04% | 79.34% | 78.96% | - |
| Selling, General & Admin | 5.08B | 5.36B | 5.7B | 5.73B | 6.28B | 6.89B | 7.25B | 7.67B | 8.23B | 6.24B |
| SG&A % of Revenue | 48.84% | 49.76% | 50.07% | 49.56% | 49.7% | 51.45% | 50.75% | 48.43% | 47.41% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 2.94B | 3.07B | 3.21B | 3.18B | 3.57B | 4.03B | 4.33B | 4.89B | 5.48B | 3M |
| Operating Income | 1.28B▲ 0% | 1.18B▼ 8.2% | 1.22B▲ 3.5% | 1.36B▲ 11.7% | 1.36B▲ 0.3% | 1B▼ 26.4% | 1.18B▲ 17.1% | 1.68B▲ 43.1% | 1.99B▲ 18.6% | 2.04B▲ 0% |
| Operating Margin % | 12.3% | 10.91% | 10.69% | 11.75% | 10.78% | 7.49% | 8.23% | 10.63% | 11.48% | 11.5% |
| Operating Income Growth % | -0.1% | -8.2% | 3.46% | 11.72% | 0.35% | -26.38% | 17.12% | 43.09% | 18.56% | - |
| EBITDA | 1.73B | 1.63B | 1.71B | 1.87B | 1.9B | 1.59B | 1.74B | 2.27B | 2.61B | 2.67B |
| EBITDA Margin % | 16.6% | 15.12% | 15% | 16.17% | 15% | 11.83% | 12.21% | 14.32% | 15.05% | 15.02% |
| EBITDA Growth % | 1.76% | -5.77% | 4.79% | 9.53% | 1.47% | -16.39% | 9.97% | 30.01% | 15.27% | 14.01% |
| D&A (Non-Cash Add-back) | 447.76M | 453.05M | 490.39M | 510.49M | 533.21M | 581.86M | 568.04M | 584.83M | 618.74M | 625.82M |
| EBIT | 1.27B | 1.18B | 1.23B | 1.36B | 1.38B | 993.15M | 1.15B | 1.68B | 2.12B | 1.66B |
| Net Interest Income | -142.77M | -154.96M | -162.73M | -106.28M | -83.67M | -126.89M | -206.67M | -186.11M | -156.07M | -114.76M |
| Interest Income | 81K | 0 | 0 | 2.8M | 1.6M | 378K | 572K | 1.43M | 1.19M | 596K |
| Interest Expense | 142.85M | 154.96M | 162.73M | 109.09M | 85.27M | 127.27M | 207.25M | 187.53M | 157.26M | 152.49M |
| Other Income/Expense | -145.17M | -140.74M | -149.57M | -106.27M | -69.78M | -137.29M | -234.96M | -183.88M | -21.87M | -21.22M |
| Pretax Income | 1.14B▲ 0% | 1.03B▼ 8.9% | 1.07B▲ 3.1% | 1.25B▲ 17.4% | 1.29B▲ 3.3% | 866.26M▼ 33.0% | 940.43M▲ 8.6% | 1.5B▲ 59.3% | 1.97B▲ 31.7% | 2.02B▲ 0% |
| Pretax Margin % | 10.9% | 9.6% | 9.37% | 10.83% | 10.23% | 6.46% | 6.58% | 9.46% | 11.36% | 11.38% |
| Income Tax | 363.7M | 236.64M | 238.79M | 299.29M | 305.68M | 209.28M | 221.12M | 334.83M | 460.96M | 472.6M |
| Effective Tax Rate % | 32.04% | 22.87% | 22.39% | 23.9% | 23.64% | 24.16% | 23.51% | 22.35% | 23.37% | 23.39% |
| Net Income | 752.3M▲ 0% | 779.71M▲ 3.6% | 814.85M▲ 4.5% | 943.95M▲ 15.8% | 991.59M▲ 5.0% | 675.61M▼ 31.9% | 717.79M▲ 6.2% | 1.14B▲ 59.1% | 1.49B▲ 30.4% | 1.52B▲ 0% |
| Net Margin % | 7.23% | 7.24% | 7.16% | 8.17% | 7.84% | 5.04% | 5.03% | 7.22% | 8.57% | 8.56% |
| Net Income Growth % | 7.1% | 3.64% | 4.51% | 15.84% | 5.05% | -31.87% | 6.24% | 59.11% | 30.36% | 27.06% |
| Net Income (Continuing) | 771.31M | 797.88M | 827.54M | 952.79M | 987.63M | 656.98M | 719.31M | 1.16B | 1.51B | 1.54B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 68.62M | 80.82M | 79.1M | 89.39M | 108.51M | 49.46M | 52.91M | 96.61M | 133.62M | 73.38M |
| EPS (Diluted) | 7.81▲ 0% | 8.32▲ 6.5% | 9.13▲ 9.7% | 10.99▲ 20.4% | 11.82▲ 7.6% | 9.14▼ 22.7% | 10.23▲ 11.9% | 16.82▲ 64.4% | 23.10▲ 37.3% | -▲ 0% |
| EPS Growth % | 9.38% | 6.53% | 9.74% | 20.37% | 7.55% | -22.67% | 11.93% | 64.42% | 37.34% | 33.73% |
| EPS (Basic) | 7.86 | 8.36 | 9.16 | 11.06 | 11.99 | 9.23 | 10.35 | 17.16 | 23.42 | - |
| Diluted Shares Outstanding | 96.33M | 93.75M | 89.04M | 85.59M | 83.69M | 73.83M | 70.13M | 67.9M | 64.46M | 0 |
| Basic Shares Outstanding | 95.65M | 93.28M | 88.76M | 85.06M | 82.52M | 73.12M | 69.32M | 66.55M | 63.58M | 0 |
| Dividend Payout Ratio | 5.08% | 4.79% | 6.5% | 1.84% | 6.65% | 8.65% | 7.73% | 4.67% | 3.44% | - |
Universal Health Services, Inc. (UHS) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.8B | 1.94B | 1.92B | 3.28B | 2.26B | 2.54B | 2.81B | 2.82B | 3.41B | 3.5B |
| Cash & Short-Term Investments | 74.42M | 105.22M | 61.27M | 1.22B | 115.3M | 102.82M | 119.44M | 125.98M | 137.8M | 119.03M |
| Cash Only | 74.42M | 105.22M | 61.27M | 1.22B | 115.3M | 102.82M | 119.44M | 125.98M | 137.8M | 119.03M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.5B | 1.51B | 1.56B | 1.73B | 1.75B | 2.02B | 2.24B | 2.18B | 2.6B | 2.75B |
| Days Sales Outstanding | 52.63 | 51.16 | 50.07 | 54.6 | 50.43 | 54.96 | 57.2 | 50.22 | 54.7 | 52.59 |
| Inventory | 136.18M | 148.21M | 159.89M | 190.42M | 206.84M | 218.52M | 216.99M | 220.94M | 232.11M | 0 |
| Days Inventory Outstanding | 44.98 | 46.29 | 46.64 | 53.96 | 52.9 | 54.1 | 51.67 | 50.79 | 51.07 | 49.51 |
| Other Current Assets | 86.5M | 174.47M | 133.93M | 138.03M | 194.78M | 198.28M | 236.66M | 291.61M | 381.57M | 635.58M |
| Total Non-Current Assets | 8.96B | 9.33B | 9.75B | 10.2B | 10.83B | 10.96B | 11.16B | 11.65B | 12.55B | 12.18B |
| Property, Plant & Equipment | 4.57B | 4.85B | 5.34B | 5.71B | 6.24B | 6.37B | 6.56B | 6.99B | 7.38B | 13.99B |
| Fixed Asset Turnover | 2.28x | 2.22x | 2.13x | 2.02x | 2.03x | 2.10x | 2.18x | 2.26x | 2.35x | 1.97x |
| Goodwill | 3.83B | 3.84B | 3.87B | 3.88B | 3.96B | 3.91B | 3.93B | 3.93B | 3.99B | 3.98B |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 76.27M | 75.88M | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 318.73M | 346.23M | 680.47M |
| Other Non-Current Assets | 563.83M | 629.83M | 523.15M | 579.97M | 579.9M | 605.89M | 579.73M | 216.19M | 254.5M | -4.74B |
| Total Assets | 10.76B▲ 0% | 11.27B▲ 4.7% | 11.67B▲ 3.6% | 13.48B▲ 15.5% | 13.09B▼ 2.8% | 13.49B▲ 3.1% | 13.97B▲ 3.5% | 14.47B▲ 3.6% | 15.96B▲ 10.3% | 15.68B▲ 0% |
| Asset Turnover | 0.97x | 0.96x | 0.98x | 0.86x | 0.97x | 0.99x | 1.02x | 1.09x | 1.09x | 1.15x |
| Asset Growth % | 4.3% | 4.68% | 3.58% | 15.5% | -2.84% | 3.06% | 3.51% | 3.6% | 10.28% | 29.09% |
| Total Current Liabilities | 1.85B | 1.45B | 1.56B | 2.48B | 1.98B | 1.91B | 2.01B | 2.21B | 3.24B | 3.24B |
| Accounts Payable | 441.98M | 445.65M | 446.96M | 570.52M | 658.9M | 636.6M | 613.97M | 632M | 750.13M | 0 |
| Days Payables Outstanding | 145.98 | 139.19 | 130.37 | 161.66 | 168.52 | 157.6 | 146.2 | 145.28 | 165.04 | 383.57 |
| Short-Term Debt | 545.62M | 63.45M | 87.55M | 332M | 48.41M | 81.45M | 126.69M | 40.06M | 821.39M | 829.14M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 376.15M | 6K | 2.4M | 5.38M | 0 | 0 | 0 |
| Other Current Liabilities | 343.22M | 472.53M | 524.63M | 410.17M | 466.35M | 470.86M | 549.47M | 622.63M | 984.56M | 2.41B |
| Current Ratio | 0.97x | 1.34x | 1.23x | 1.32x | 1.14x | 1.33x | 1.40x | 1.27x | 1.05x | 1.05x |
| Quick Ratio | 0.90x | 1.24x | 1.12x | 1.25x | 1.04x | 1.21x | 1.29x | 1.17x | 0.98x | 0.98x |
| Cash Conversion Cycle | -48.38 | -41.74 | -33.66 | -53.11 | -65.19 | -48.54 | -37.33 | -44.27 | -59.27 | -281.48 |
| Total Non-Current Liabilities | 3.86B | 4.35B | 4.52B | 4.59B | 4.91B | 5.61B | 5.75B | 5.5B | 5.31B | 4.91B |
| Long-Term Debt | 3.49B | 3.94B | 3.9B | 3.52B | 4.14B | 4.73B | 4.79B | 4.46B | 4.26B | 4.3B |
| Capital Lease Obligations | 0 | 0 | 270.08M | 278.3M | 304.62M | 395.52M | 382.56M | 376.24M | 426.1M | 1.12B |
| Deferred Tax Liabilities | 54.96M | 49.66M | 25.07M | 5.58M | 0 | 0 | 0 | 0 | 435.14M | 438.38M |
| Other Non-Current Liabilities | 306.3M | 361.81M | 329.93M | 458.55M | 464.76M | 487.67M | 584.01M | 655.81M | 187.11M | 2.01B |
| Total Liabilities | 5.7B | 5.8B | 6.09B | 7.07B | 6.9B | 7.52B | 7.77B | 7.71B | 8.55B | 8.11B |
| Total Debt | 4.04B | 4B | 4.31B | 4.19B | 4.56B | 5.27B | 5.37B | 4.96B | 5.51B | 5.13B |
| Net Debt | 3.97B | 3.89B | 4.25B | 2.97B | 4.44B | 5.17B | 5.25B | 4.83B | 5.37B | 5.01B |
| Debt / Equity | 0.80x | 0.73x | 0.77x | 0.65x | 0.74x | 0.88x | 0.87x | 0.73x | 0.74x | 0.74x |
| Debt / EBITDA | 2.34x | 2.46x | 2.53x | 2.24x | 2.40x | 3.32x | 3.08x | 2.19x | 2.11x | 1.92x |
| Net Debt / EBITDA | 2.29x | 2.39x | 2.49x | 1.59x | 2.34x | 3.26x | 3.01x | 2.13x | 2.06x | 2.06x |
| Interest Coverage | 8.88x | 7.63x | 7.55x | 12.45x | 16.15x | 7.80x | 5.53x | 8.96x | 13.51x | 10.92x |
| Total Equity | 5.06B▲ 0% | 5.47B▲ 8.1% | 5.58B▲ 2.1% | 6.41B▲ 14.7% | 6.2B▼ 3.3% | 5.97B▼ 3.7% | 6.2B▲ 3.9% | 6.76B▲ 9.0% | 7.41B▲ 9.6% | 7.6B▲ 0% |
| Equity Growth % | 9.79% | 8.14% | 2.07% | 14.75% | -3.25% | -3.68% | 3.88% | 9.04% | 9.56% | 38.12% |
| Book Value per Share | 52.51 | 58.35 | 62.70 | 74.85 | 74.06 | 80.86 | 88.44 | 99.61 | 114.94 | 114.94 |
| Total Shareholders' Equity | 4.99B | 5.39B | 5.5B | 6.32B | 6.09B | 5.92B | 6.15B | 6.67B | 7.28B | 7.53B |
| Common Stock | 942K | 914K | 867K | 851K | 771K | 710K | 672K | 650K | 611K | 7.46B |
| Retained Earnings | 4.98B | 5.38B | 5.47B | 6.27B | 6.06B | 5.93B | 6.8B | 7.37B | 7.99B | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 7.18M | 4.24M | 31.89M | 48.12M | 30.29M | -9.67M | -650.6M | -706.5M | -717.57M | 0 |
| Minority Interest | 68.62M | 80.82M | 79.1M | 89.39M | 108.51M | 49.46M | 52.91M | 96.61M | 133.62M | 73.38M |
Universal Health Services, Inc. (UHS) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.18B | 1.34B | 1.44B | 2.36B | 883.7M | 996.02M | 1.27B | 2.07B | 1.86B | 1.86B |
| Operating CF Margin % | 11.36% | 12.45% | 12.64% | 20.42% | 6.99% | 7.43% | 8.88% | 13.06% | 10.74% | - |
| Operating CF Growth % | -8.22% | 13.39% | 7.28% | 64.08% | -62.56% | 12.71% | 27.29% | 63.05% | -9.81% | -6.03% |
| Net Income | 771.31M | 797.88M | 827.54M | 952.79M | 987.63M | 656.98M | 717.49M | 1.16B | 1.51B | 1.52B |
| Depreciation & Amortization | 447.88M | 453.08M | 490.39M | 510.49M | 533.21M | 581.86M | 568.04M | 584.83M | 618.74M | 625.82M |
| Stock-Based Compensation | 56.74M | 66.58M | 69.43M | 65.84M | 73.69M | 85.38M | 87.72M | 99.35M | 95.69M | 72.48M |
| Deferred Taxes | 0 | 49.52M | 90.09M | 3.32M | 26.05M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -79.19M | -76.15M | -97.78M | -109.76M | 0 | -83.85M | -124.34M | -198.95M | -85.32M | -314.13M |
| Working Capital Changes | -14.16M | 49.98M | 58.79M | 940.81M | -736.89M | -244.35M | 17.07M | 418.76M | -275.89M | -2.1M |
| Change in Receivables | -24.72M | -42.24M | -42.06M | -145.9M | -8.87M | -258.34M | -182.44M | 67.36M | -317.99M | -223.47M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -624.4M | -813.4M | -688.41M | -802.56M | -914.47M | -647.3M | -763.27M | -911.11M | -1.07B | -996.9M |
| Capital Expenditures | -609.43M | -811.67M | -663.52M | -734.21M | -855.66M | -734M | -743.05M | -943.81M | -1.02B | -1.01B |
| CapEx % of Revenue | 5.85% | 7.53% | 5.83% | 6.35% | 6.77% | 5.48% | 5.2% | 5.96% | 5.85% | - |
| Acquisitions | -15.08M | -15.23M | -14.58M | -54.78M | -105.31M | -20.31M | -3.73M | -18.72M | -31.94M | -26.24M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 108K | 13.5M | -10.31M | 8.07M | 46.51M | 12M | -16.51M | 51.42M | 28.69M | 44.17M |
| Cash from Financing | -519.15M | -492.2M | -845.04M | -384.86M | -1.07B | -318.4M | -493.94M | -1.14B | -749.73M | -880.2M |
| Debt Issued (Net) | -102.01M | -53.04M | -17.92M | -160.97M | 217.11M | 615.95M | 99.62M | -429.75M | 241.65M | 98.69M |
| Equity Issued (Net) | -364.4M | -397.43M | -770.5M | -206.72M | -1.22B | -832.92M | -547.36M | -655.68M | -951.22M | -731.5M |
| Dividends Paid | -38.21M | -37.34M | -53M | -17.34M | -65.9M | -58.45M | -55.48M | -53.35M | -51.27M | -50.71M |
| Share Repurchases | -364.4M | -397.43M | -770.5M | -206.72M | -1.22B | -832.92M | -547.36M | -670.75M | -967.95M | -908.41M |
| Other Financing | -14.54M | -4.4M | -3.61M | 172K | 715K | -42.99M | 9.28M | -6.09M | 11.11M | -196.69M |
| Net Change in Cash | 40.68M▲ 0% | 32.39M▼ 20.4% | -94.02M▼ 390.3% | 1.17B▲ 1348.2% | -1.1B▼ 193.8% | 21.9M▲ 102.0% | 13.63M▼ 37.8% | 10.28M▼ 24.6% | 46.57M▲ 352.9% | -990K▲ 0% |
| Free Cash Flow | 573.15M▲ 0% | 529.22M▼ 7.7% | 774.95M▲ 46.4% | 1.63B▲ 109.8% | 28.04M▼ 98.3% | 262.02M▲ 834.6% | 524.74M▲ 100.3% | 1.12B▲ 114.1% | 849.25M▼ 24.4% | 894.02M▲ 0% |
| FCF Margin % | 5.51% | 4.91% | 6.81% | 14.07% | 0.22% | 1.96% | 3.67% | 7.1% | 4.89% | 5.03% |
| FCF Growth % | 330.11% | -7.66% | 46.43% | 109.81% | -98.28% | 834.59% | 100.27% | 114.07% | -24.4% | -15.37% |
| FCF per Share | 5.95 | 5.65 | 8.70 | 19.00 | 0.33 | 3.55 | 7.48 | 16.54 | 13.17 | 13.17 |
| FCF Conversion (FCF/Net Income) | 1.57x | 1.72x | 1.77x | 2.50x | 0.89x | 1.47x | 1.77x | 1.81x | 1.25x | 0.59x |
| Interest Paid | 135.53M | 150.29M | 157.41M | 112.6M | 75.61M | 120.14M | 200.45M | 168.27M | 0 | 75.33M |
| Taxes Paid | 370.86M | 293.84M | 260.62M | 286.25M | 362.98M | 250.76M | 257.9M | 325.43M | 0 | 350.33M |
Universal Health Services, Inc. (UHS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 15.57% | 14.81% | 14.74% | 15.75% | 15.73% | 11.1% | 11.79% | 17.62% | 21.01% | 20.65% |
| Return on Invested Capital (ROIC) | 10.83% | 9.59% | 9.5% | 10.61% | 10.21% | 6.91% | 7.81% | 10.95% | 12.27% | 12.27% |
| Gross Margin | 89.38% | 89.15% | 89% | 88.86% | 88.71% | 89% | 89.27% | 89.97% | 90.45% | 67.62% |
| Net Margin | 7.23% | 7.24% | 7.16% | 8.17% | 7.84% | 5.04% | 5.03% | 7.22% | 8.57% | 8.56% |
| Debt / Equity | 0.80x | 0.73x | 0.77x | 0.65x | 0.74x | 0.88x | 0.87x | 0.73x | 0.74x | 0.74x |
| Interest Coverage | 8.88x | 7.63x | 7.55x | 12.45x | 16.15x | 7.80x | 5.53x | 8.96x | 13.51x | 10.92x |
| FCF Conversion | 1.57x | 1.72x | 1.77x | 2.50x | 0.89x | 1.47x | 1.77x | 1.81x | 1.25x | 0.59x |
| Revenue Growth | 6.59% | 3.48% | 5.63% | 1.59% | 9.37% | 5.99% | 6.59% | 10.82% | 9.71% | 10.42% |
Universal Health Services, Inc. (UHS) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 28, 2026·SEC
Apr 24, 2026·SEC
Mar 30, 2026·SEC
Universal Health Services, Inc. (UHS) stock FAQ — growth, dividends, profitability & financials explained
Universal Health Services, Inc. (UHS) reported $17.76B in revenue for fiscal year 2025. This represents a 1392% increase from $1.19B in 1996.
Universal Health Services, Inc. (UHS) grew revenue by 9.7% over the past year. This is steady growth.
Yes, Universal Health Services, Inc. (UHS) is profitable, generating $1.52B in net income for fiscal year 2025 (8.6% net margin).
Yes, Universal Health Services, Inc. (UHS) pays a dividend with a yield of 0.47%. This makes it attractive for income-focused investors.
Universal Health Services, Inc. (UHS) has a return on equity (ROE) of 21.0%. This is excellent, indicating efficient use of shareholder capital.
Universal Health Services, Inc. (UHS) generated $894.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Universal Health Services, Inc. (UHS) financial analysis — history, returns, DCA and operating performance tools
Analyst verdict, bull/bear case, risk factors and peer comparison
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates